426 related articles for article (PubMed ID: 32621644)
21. Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.
Jobbagy S; Vitturi DA; Salvatore SR; Pires MF; Rowart P; Emlet DR; Ross M; Hahn S; St Croix C; Wendell SG; Subramanya AR; Straub AC; Tan RJ; Schopfer FJ
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31941842
[TBL] [Abstract][Full Text] [Related]
22. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
Moosavi SM; Karimi Z
Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
[TBL] [Abstract][Full Text] [Related]
23. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy.
Schoot TS; Molmans THJ; Grootens KP; Kerckhoffs APM
Eur Neuropsychopharmacol; 2020 Feb; 31():16-32. PubMed ID: 31837914
[TBL] [Abstract][Full Text] [Related]
25. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Inoue M; Nakai K; Mitsuiki K
CEN Case Rep; 2021 Feb; 10(1):64-68. PubMed ID: 32772236
[TBL] [Abstract][Full Text] [Related]
26. Acquired nephrogenic diabetes insipidus.
Khanna A
Semin Nephrol; 2006 May; 26(3):244-8. PubMed ID: 16713497
[TBL] [Abstract][Full Text] [Related]
27. Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy.
Kamath C; Govindan J; Premawardhana AD; Wood SJ; Adlan MA; Premawardhana LD
Clin Med (Lond); 2013 Aug; 13(4):407-10. PubMed ID: 23908517
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and correlates of renal disease in older lithium users: a population-based study.
Rej S; Shulman K; Herrmann N; Harel Z; Fischer HD; Fung K; Gruneir A
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1075-82. PubMed ID: 24566239
[TBL] [Abstract][Full Text] [Related]
29. Persistent nephrogenic diabetes insipidus following lithium therapy.
Thompson CJ; France AJ; Baylis PH
Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen attenuates development of lithium-induced nephrogenic diabetes insipidus in rats.
Tingskov SJ; Hu S; Frøkiær J; Kwon TH; Wang W; Nørregaard R
Am J Physiol Renal Physiol; 2018 May; 314(5):F1020-F1025. PubMed ID: 29357422
[TBL] [Abstract][Full Text] [Related]
31. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
32. Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus.
Bedford JJ; Leader JP; Jing R; Walker LJ; Klein JD; Sands JM; Walker RJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F812-20. PubMed ID: 18216143
[TBL] [Abstract][Full Text] [Related]
33. Partial nephrogenic diabetes insipidus associated with lithium therapy.
Nandoshvili E; Hyer S; Johri N
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31494590
[TBL] [Abstract][Full Text] [Related]
34. Lithium-induced nephrogenic diabetes insipidus.
Stone KA
J Am Board Fam Pract; 1999; 12(1):43-7. PubMed ID: 10050642
[TBL] [Abstract][Full Text] [Related]
35. Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.
Poulsen SB; Kristensen TB; Brooks HL; Kohan DE; Rieg T; Fenton RA
JCI Insight; 2017 Apr; 2(7):e91042. PubMed ID: 28405619
[TBL] [Abstract][Full Text] [Related]
36. [Water, lithium and sodium: watch out for dangerous injuries].
Fayolle M; Souweine JS; Mathieu O; Bargnoux AS; Cristol JP; Badiou S
Ann Biol Clin (Paris); 2020 Aug; 78(4):449-453. PubMed ID: 32618565
[TBL] [Abstract][Full Text] [Related]
37. 4-PBA improves lithium-induced nephrogenic diabetes insipidus by attenuating ER stress.
Zheng P; Lin Y; Wang F; Luo R; Zhang T; Hu S; Feng P; Liang X; Li C; Wang W
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F763-F776. PubMed ID: 27385737
[TBL] [Abstract][Full Text] [Related]
38. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
Kotnik P; Nielsen J; Kwon TH; Krzisnik C; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2005 May; 288(5):F1053-68. PubMed ID: 15644490
[TBL] [Abstract][Full Text] [Related]
40. [Lithium-induced nephrogenic diabetes insipidus during acute intoxication: a case report].
Echater S; Hasnaoui M; Lechner E
Pan Afr Med J; 2023; 45():77. PubMed ID: 37663626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
